Branch Point

Branchpoint Biosciences is a biotechnology company focused on the systematic discovery of RNA-based biomarkers and therapeutic targets. The company utilizes a proprietary platform to map RNA branch points, which are critical but often overlooked elements of the RNA splicing process. By identifying aberrant splicing events and cryptic branch points associated with disease, Branchpoint aims to develop precision medicines for oncology and rare genetic conditions. Their technology provides a high-resolution view of the transcriptome, enabling the targeting of RNA processing pathways that were previously difficult to characterize.